Lung nodules are small growths in your lungs, less than 30 millimeters in diameter. Many nodules aren’t cancerous, but the risk becomes higher with increased size. A lung nodule is an irregular ...

After housing giant pandas for a quarter-century, Zoo Atlanta in the US state of Georgia announced Friday (Sept 20) that its ...

With flu season on the horizon, the American Lung Association is reminding the public of the importance of getting an annual ...

June 13, 2024 — The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been ... Lung Cancer Study Offers ...

Evidence that White patients with lung disease are disproportionately more likely to get a lung transplant compared with minority populations hasn't shifted much in recent years. And while ...

Sep. 12, 2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not ...

It works by presenting the immune system with tumour markers from non-small cell lung cancer, the most common form of the disease, to prime the body to fight cancer cells expressing these markers.

The study repeatedly underscores that Indigenous communities are consistently underrepresented in medical research about cancer, and Taparra explained that this is in part explainable by the ...

As your White House correspondent ... every step of the way to the November election A new vaccine that fights lung cancer is being tested for the first time on patients in the UK.

The first vaccine that aims to kill the most common form of lung cancer and keep it from coming back is being tested in Maryland and Virginia as part of a global clinical trial. Known as BNT116 ...

A 67-year-old London man with lung cancer has been the first to receive a new cancer vaccine as part of an international trial. The early-stage research will test the immune therapy’s safety and ...

Adjuvant durvalumab failed to improve disease-free survival in resected EGFR- or ALK-negative non-small cell lung cancer.